Macquarie Group LTD Abbott Laboratories Transaction History

Macquarie Group LTD

$87.4 Billion
Q1 2024

A detailed history of Macquarie Group LTD transactions in Abbott Laboratories stock. As of the latest transaction made, Macquarie Group LTD holds 1,384,451 shares of ABT stock, worth $144 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares

1,384,451

Previous 1,158,014 19.55%

Holding current value

$144 Million

Previous $127 Million 23.45%

% of portfolio

0.18%

Previous 0.15%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$109.52 - $120.96 $24.8 Million - $27.4 Million	226,437 Added 19.55%	1,384,451 $157 Million
Q4 2023 Feb 14, 2024	SELL	$90.19 - $110.4 $15.1 Million - $18.5 Million	-167,192 Reduced 12.62%	1,158,014 $127 Million
Q3 2023 Nov 14, 2023	BUY	$95.53 - $114.62 $9.11 Million - $10.9 Million	95,346 Added 7.75%	1,325,206 $128 Million
Q2 2023 Aug 14, 2023	BUY	$100.78 - $112.29 $45.9 Million - $51.1 Million	455,470 Added 58.82%	1,229,860 $134 Million
Q1 2023 May 15, 2023	BUY	$96.86 - $114.01 $19.7 Million - $23.2 Million	203,787 Added 35.71%	774,390 $78.4 Million

Q4 2022 Feb 21, 2023	BUY	$95.06 - $111.52 $809,626 - $949,815	8,517 Added 1.52%	570,603 $62.7 Million
Q3 2022 Nov 14, 2022	SELL	$96.76 - $112.03 $4.05 Million - $4.69 Million	-41,905 Reduced 6.94%	562,086 $54.4 Million
Q2 2022 Aug 15, 2022	SELL	$102.07 - $123.37 $2.55 Million - $3.09 Million	-25,029 Reduced 3.98%	603,991 $65.6 Million
Q1 2022 May 16, 2022	SELL	$114.02 - $139.04 $2.64 Million - $3.21 Million	-23,110 Reduced 3.54%	629,020 $74.5 Million
Q4 2021 Feb 11, 2022	BUY	$115.53 - $141.46 $23.4 Million - $28.6 Million	202,236 Added 44.95%	652,130 $91.8 Million
Q3 2021 Nov 12, 2021	SELL	$116.66 - $129.06 $154,924 - $171,391	-1,328 Reduced 0.29%	449,894 $53.1 Million
Q2 2021 Aug 13, 2021	BUY	$105.79 - $124.53 $21.2 Million - $25 Million	200,521 Added 79.98%	451,222 $52.3 Million
Q1 2021 May 14, 2021	SELL	$108.84 - $128.23 $1.45 Million - $1.71 Million	-13,321 Reduced 5.05%	250,701 $30 Million
Q4 2020 Feb 16, 2021	SELL	$105.0 - $114.42 $61.7 Million - $67.2 Million	-587,278 Reduced 68.99%	264,022 $28.9 Million
Q3 2020 Nov 13, 2020	SELL	$91.64 - $111.29 $596 Million - $723 Million	-6,499,373 Reduced 88.42%	851,300 $92.6 Million
Q2 2020 Aug 11, 2020	SELL	$76.57 - $98.0 $92.4 Million - $118 Million	-1,206,620 Reduced 14.1%	7,350,673 $672 Million
Q1 2020 May 15, 2020	SELL	$62.82 - $91.86 $136 Million - $199 Million	-2,169,633 Reduced 20.23%	8,557,293 $675 Million
Q4 2019 Feb 14, 2020	BUY	$78.51 - $87.4 $92.7 Million - $103 Million	1,181,225 Added 12.37%	10,726,926 $932 Million
Q3 2019 Nov 14, 2019	SELL	$81.84 - $88.74 $4.58 Million - $4.97 Million	-56,022 Reduced 0.58%	9,545,701 $799 Million
Q2 2019 Aug 14, 2019	SELL	$72.88 - $85.0 $39.8 Million - $46.4 Million	-546,230 Reduced 5.38%	9,601,723 $808 Million
Q1 2019 May 15, 2019	SELL	$66.22 - $80.06 $33.8 Million - $40.8 Million	-510,190 Reduced 4.79%	10,147,953 $811 Million
Q4 2018 Feb 15, 2019	SELL	$65.56 - $74.27 $37.1 Million - $42.1 Million	-566,346 Reduced 5.05%	10,658,143 $771 Million
Q3 2018 Nov 15, 2018	SELL	$60.81 - $73.36 $42.2 Million - $51 Million	-694,707 Reduced 5.83%	11,224,489 $823 Million
Q2 2018 Aug 14, 2018	SELL	$57.57 - $63.54 $13.3 Million - $14.6 Million	-230,211 Reduced 1.89%	11,919,196 $727 Million
Q1 2018 May 11, 2018	SELL	$56.27 - $63.62 $47.5 Million - $53.7 Million	-844,281 Reduced 6.5%	12,149,407 $728 Million
Q4 2017 Feb 15, 2018	SELL	$53.68 - $57.47 $44.6 Million - $47.7 Million	-830,718 Reduced 6.01%	12,993,688 $742 Million
Q3 2017 Nov 08, 2017	BUY	$48.06 - $53.64 $664 Million - $742 Million	13,824,406	13,824,406 $738 Million

Others Institutions Holding ABT

# of Institutions

3,127

Shares Held

1.29B

Call Options Held

8.43M

Put Options Held

8.71M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $182B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Account

Macquarie Group LTD Abbott Laboratories Transaction History